Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Ovarian Neoplasms 2Carcinoma, Ovarian Epithelial 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Small Cell Lung Carcinoma 1Lung Neoplasms 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1

Interventions

Radiotherapy 31Carboplatin 29Cisplatin 28Paclitaxel 26Gemcitabine 14Docetaxel 14Etoposide 13Bevacizumab 9Ramucirumab 7Pemetrexed 6Magnetic Resonance Spectroscopy 5Erlotinib Hydrochloride 5Cetuximab 5pembrolizumab 4cediranib 4Vinorelbine 4Specimen Handling 4Radiosurgery 4Gene Expression Profiling 4Filgrastim 4Amplified Fragment Length Polymorphism Analysis 4dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Surgical Procedures, Operative 3Radiotherapy, Conformal 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lung Neoplasms × rubitecan × Clear all
NCT00006082 2012-09-24

Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
38 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡